IBO vs PG · rev $18.0K vs P/E 25, rev $84.28B
Impact BioMedical, Inc. (IBO) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Impact BioMedical, Inc. (IBO) is a biotechnology company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported IBO revenue for 2025-09-30 was $18.0K. Net income was -$1.5M. IBO currently screens at market cap $7.6M.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
IBO currently screens at market cap $7.6M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the IBO and PG stock pages for the full models.
Not investment advice.